CIK 0000939767
- Large accelerated filer
EXELIXIS, INC.
Sign in to watch- Ticker
- EXEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jan 1
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043257395
- Phone
- +1 650-837-7000
- Business address
- 1851 HARBOR BAY PARKWAY, ALAMEDA, CA, 94502
- Former names
- EXELIXIS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-11-15 | Senner Christopher J. EVP and CFO | Shares withheld for taxes | −46,920 | $18.10 | $849K | 357,815 |
| 2021-11-15 | Hessekiel Jeffrey EVP and General Counsel | Shares withheld for taxes | −6,557 | $18.10 | $119K | 626,268 |
| 2021-11-15 | Hessekiel Jeffrey EVP and General Counsel | Shares withheld for taxes | −1,311 | $18.10 | $24K | 624,957 |
| 2021-11-15 | Hessekiel Jeffrey EVP and General Counsel | Shares withheld for taxes | −46,743 | $18.10 | $846K | 578,214 |
| 2021-11-15 | MORRISSEY MICHAEL President and CEO | Shares withheld for taxes | −10,530 | $18.10 | $191K | 550,538 |
| 2021-11-15 | MORRISSEY MICHAEL President and CEO | Shares withheld for taxes | −6,118 | $18.10 | $111K | 544,420 |
| 2021-11-15 | MORRISSEY MICHAEL President and CEO | Shares withheld for taxes | −177,132 | $18.10 | $3.2M | 367,288 |
| 2021-11-15 | Lamb Peter EVP, Scientific Strategy & CSO | Option exercise | +47,500 | $6.21 | $295K | 458,740 |
| 2021-11-15 | Lamb Peter EVP, Scientific Strategy & CSO | Sale | −47,500 | $18.09 | $859K | 411,240 |
| 2021-11-15 | Lamb Peter EVP, Scientific Strategy & CSO | Shares withheld for taxes | −6,818 | $18.10 | $123K | 404,422 |
| 2021-11-15 | Lamb Peter EVP, Scientific Strategy & CSO | Shares withheld for taxes | −2,323 | $18.10 | $42K | 402,099 |
| 2021-11-15 | Lamb Peter EVP, Scientific Strategy & CSO | Shares withheld for taxes | −53,022 | $18.10 | $960K | 349,077 |
| 2021-11-15 | Lamb Peter EVP, Scientific Strategy & CSO | Option exercise · Option (right to buy) | −47,500 | 47,500 | ||
| 2021-11-01 | Hessekiel Jeffrey EVP and General Counsel | Sale | −5,117 | $22.03 | $113K | 632,825 |
| 2021-10-22 | MORRISSEY MICHAEL President and CEO | Grant or award | +94,002 | 585,815 | ||
| 2021-10-22 | MORRISSEY MICHAEL President and CEO | Shares withheld for taxes | −24,747 | $21.33 | $528K | 561,068 |
| 2021-10-15 | Lamb Peter EVP, Scientific Strategy & CSO | Option exercise | +47,500 | $6.21 | $295K | 458,740 |
| 2021-10-15 | Lamb Peter EVP, Scientific Strategy & CSO | Sale | −47,500 | $21.92 | $1.0M | 411,240 |
| 2021-10-15 | Lamb Peter EVP, Scientific Strategy & CSO | Option exercise · Option (right to buy) | −47,500 | 95,000 | ||
| 2021-05-17 | Hessekiel Jeffrey EVP, General Counsel & Sec | Sale | −18,000 | $25.39 | $457K | 604,822 |
Page 29 of 29 · 580 trades